Paper42226962
Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors.
Zhao Y and 8 others. Int J Nanomedicine, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors. Papers, record 42226962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226962
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Antineoplastic Agents | Major topic |
| Nanoparticle Drug Delivery System | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Animals | |
| Nanomedicine |
Source PubMed
References286
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30260234 | Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects. | Artif Cells Nanomed Biotechnol | 2018 | https://conductscience.org/library/papers/30260234 | PubMed |
| 2 | 33809479 | Strategies for Cancer Treatment Based on Photonic Nanomedicine. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/33809479 | PubMed |
| 3 | 36108810 | Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer. | J Control Release | 2022 | https://conductscience.org/library/papers/36108810 | PubMed |
| 4 | 41794332 | Protein-based nanocarriers in the management of hard-to-treat solid tumours. | Adv Drug Deliv Rev | 2026 | https://conductscience.org/library/papers/41794332 | PubMed |
| 5 | 40177124 | Folic Acid-Targeted Liposome-Based Nanoparticle Loaded with Sorafenib for Liver Cancer Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40177124 | PubMed |
| 6 | 34740764 | Mechanisms of immune response to inorganic nanoparticles and their degradation products. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/34740764 | PubMed |
| 7 | 36796298 | Novel construction of multifunctional photo-responsive and nucleic acid-triggered doxorubicin-releasing liposomes for cancer therapy. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/36796298 | PubMed |
| 8 | 41326237 | CD47-targeted liposomal chemotherapy upregulates CD47 expression and induces microsatellite instability which enhances cancer immunotherapy. | J Control Release | 2025 | https://conductscience.org/library/papers/41326237 | PubMed |
| 9 | 32235073 | CD271 antibody-functionalized HGNs for targeted photothermal therapy of osteosarcoma stem cells. | Nanotechnology | 2020 | https://conductscience.org/library/papers/32235073 | PubMed |
| 10 | 40412657 | VPS9D1-AS1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer. | J Control Release | 2025 | https://conductscience.org/library/papers/40412657 | PubMed |
| 11 | 37551087 | Photoresponsive Inorganic Nanomaterials in Oncology. | Technol Cancer Res Treat | 2023 | https://conductscience.org/library/papers/37551087 | PubMed |
| 12 | 34550040 | Topically applied liposome-in-hydrogels for systematically targeted tumor photothermal therapy. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34550040 | PubMed |
| 13 | 31698897 | Gradient Redox-Responsive and Two-Stage Rocket-Mimetic Drug Delivery System for Improved Tumor Accumulation and Safe Chemotherapy. | Nano Lett | 2019 | https://conductscience.org/library/papers/31698897 | PubMed |
| 14 | 36944946 | Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36944946 | PubMed |
| 15 | 27291325 | Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis. | Sci Rep | 2016 | https://conductscience.org/library/papers/27291325 | PubMed |
| 16 | 31294482 | Toxic effects and involved molecular pathways of nanoparticles on cells and subcellular organelles. | J Appl Toxicol | 2020 | https://conductscience.org/library/papers/31294482 | PubMed |
| 17 | 35195416 | NIR Activated Upper Critical Solution Temperature Polymeric Micelles for Trimodal Combinational Cancer Therapy. | Biomacromolecules | 2022 | https://conductscience.org/library/papers/35195416 | PubMed |
| 18 | 37153517 | Iron/iron oxide-based magneto-electrochemical sensors/biosensors for ensuring food safety: recent progress and challenges in environmental protection. | RSC Adv | 2023 | https://conductscience.org/library/papers/37153517 | PubMed |
| 19 | 23676854 | Roles of the hepcidin-ferroportin axis and iron in cancer. | Eur J Cancer Prev | 2014 | https://conductscience.org/library/papers/23676854 | PubMed |
| 20 | 27292613 | Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer. | Acta Pharmacol Sin | 2016 | https://conductscience.org/library/papers/27292613 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943973 | A Review of KSHV: Lifecycle, Tumorigenesis, Immune Evasion and Therapeutic Strategies. | Viruses | 2026 | https://conductscience.org/library/papers/42943973 | PubMed |
| 42793129 | Bufalin-Loaded Multifunctional Nanodrugs for Cancer Therapy: Mechanisms, Delivery Strategies, and Translational Perspectives. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793129 | PubMed |
| 42657191 | Graphene and Graphene Oxide-Based Nanocarriers for Targeted Delivery of Mitoxantrone in Cancer Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42657191 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226962
GET https://conductscience.org/api/papers/v1/42226962/references?page=2